Skip to main content

Advertisement

Table 1 Characteristics of colorectal carcinoma patients and prognostic effect on DFS and OVS.

From: Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma

  Number (%) DFS (months) P value OVS (months) P value
Age       
   60≤ 17 56.7 10.5 0.0184 34 0.216
   >60 13 43.3 18.9   48.4  
Sex       
   Female 12 40 18.2 0.221 42.2 0.782
   Male 18 60 11.5   39  
Tumor location       
   Colon 24 80 10.1 0.0272 34.8 0.0111
   Rectum 6 20 30.3   62  
Dukes Stage       
   A -      
   B 8 26.7 25.7 0.0002 50.2 0.0076
   C 11 36.7 17.8   48.4  
   D 11 36.7 2.18   24.9  
Histologic type       
   Adeno Ca 27 90 14.92 0.455 42.55 0.0243
   Mucinous Ca 1 3.3 10.0   13.0  
   Adenosquamous Ca 1 3.3 13.0   27.0  
   Adenocarcinoid Ca 1 3.3 0.0   20.0  
Differentiation       
   Well differentiated 6 20 8.3 0.0407 46.3 0.002
   Moderately differentiated 19 63.3 18.6   43.9  
   Poorly differentiated 4 13.3 5.5   21.7  
   Colloid (mucinous) 1 3.3 0.0   9  
Metastatic Lymph Node       
   Absent 8 26.7 25.7 0.0398 50.25 0.259
   Present 22 73.3 10.0   36.68  
Preoperative Metastasis       
   Absent 19 64.3 21.1 0.000 49 0.0018
   Present 11 36.6 2.18   24.91  
Serum MUC5AC Ab level       
   Negative 12 40 19.91 0.153 50.0 0.052
   Positive 18 60 10.38   33.83  
  1. DFS = Disease Free Survival
  2. OVS = Overall Survival